Tenax Therapeutics (TENX) Receivables - Other (2012 - 2013)
Tenax Therapeutics (TENX) posted quarterly Receivables - Other of $500000.0 for Q2 2013, up 3244.48% year-over-year from $14950.0 in Q2 2012, and up 1615.62% on a QoQ basis from $29144.0 in Q1 2013.
Tenax Therapeutics (TENX) Receivables - Other (2012 - 2013) Analysis & Trends
Tenax Therapeutics has reported Receivables - Other for 2 years, with the latest figure at $500000.0 in Q2 2013.
- Receivables - Other for Q2 2013 came in at $500000.0, up 3244.48% year-over-year; the trailing twelve-month figure through Apr 2013 was $500000.0 (up 3244.48% YoY), and the FY2013 annual result was $500000.0, up 3244.48% from the prior year.
- Receivables - Other grew to $500000.0 in Q2 2013, from $29144.0 in the prior quarter.
- Over five years, Receivables - Other peaked at $500000.0 in Q2 2013 and troughed at $14950.0 in Q2 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Tenax Therapeutics | 78.47 Mn | 78.47 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2013 | 500,000.00 |
| Apr 30, 2013 | 500,000.00 |
| Jan 31, 2013 | 29,144.00 |
| Jan 31, 2013 | 29,144.00 |
| Jul 31, 2012 | 50,701.00 |
| Jul 31, 2012 | 50,701.00 |
| Apr 30, 2012 | 14,950.00 |
| Apr 30, 2012 | 14,950.00 |